Evidence for an Association of the R485K Polymorphism in the Coagulation Factor V Gene with Severe Preeclampsia from Screening 35 Polymorphisms in 27 Candidate Genes

Hideki Watanabe; Hiromi Hamada; Kimiko Yamakawa-Kobayashi; Hiroyuki Yoshikawa; Tadao Arinami

doi:10.1055/s-0037-1616777

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 86(06): 1594-1595
DOI: 10.1055/s-0037-1616777

Letters to the Editor

Schattauer GmbH

Evidence for an Association of the R485K Polymorphism in the Coagulation Factor V Gene with Severe Preeclampsia from Screening 35 Polymorphisms in 27 Candidate Genes

Hideki Watanabe

¹Department of Obstetrics and Gynecology, Institute of Clinical Medicine

,

Hiromi Hamada

¹Department of Obstetrics and Gynecology, Institute of Clinical Medicine

,

Kimiko Yamakawa-Kobayashi

²Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan

,

Hiroyuki Yoshikawa

¹Department of Obstetrics and Gynecology, Institute of Clinical Medicine

,

Tadao Arinami

²Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan

References
1 Morgan T, Ward K. New insights into the genetics of preeclampsia. Semin Perinatol 1999; 23: 14-23.
2 American College of Obstetricians and Gynecologists.. ACOG technical bulletin. Hypertension in pregnancy. Number 219. Int J Gynaecol Obstet 1996; 53: 175-83.
3 Le W, Yu JD, Lu L, Tao R, You B, Cai X, Cao WJ, Huang W, He RM, Zhu DL, Chen Z, Gong LS. Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population. Clin Genet 2000; 57: 296-303.
4 Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. Blood 1995; 86: 219-24.
5 Hiyoshi M, Arnutti P, Prayoonwiwat W, Nathalang O, Suwanasophon C, Kokaseam R, Hashimoto S, Takubo T, Tagawa S, Fukui M, Tatsumi N. A polymorphism nt 1628G→A (R485K) in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai population. Thromb Haemost 1998; 80: 705-6.
6 Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77: 1052-4.
7 Nagy B, Toth T, Rigo Jr J, Karadi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet 1998; 53: 478-81.
8 Rigo Jr J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000; 19: 163-72.
9 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
10 Ozawa T, Niiya K, Sakuragawa N. Absence of factor V Leiden in the Japanese. Thromb Res 1996; 81: 595-6.
11 Ro A, Hara M, Takada A. The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 1999; 82: 1769.
12 Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34: 525-6.
13 National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.